Sensex, Nifty, Share Prices LIVE: The upmove in Hindalco Industries has gained momentum. The stock has made a bullish breakout above the key resistance level of ₹712 this week. On the charts, the momentum is strong. The region around ₹710 will now act as a good support and limit the downside. Fresh buyers are likely to come in to the market around ₹710.
Asian stocks extend rally on China, US sentiment: Markets wrap (27-09-2024)
Asian stocks continued to rise as China’s new stimulus measures and record highs in US benchmarks boosted market sentiment. The S&P 500 reached its 42nd closing record this year, while Chinese shares listed in the US surged. Traders await further details on China’s stimulus and upcoming US economic indicators.
‘Punjab CM Mann is in third or fourth stage of liver cirrhosis,’ claims SAD’s Bikram Singh Majithia (27-09-2024)
Akali Dal (SAD) leader Bikram Singh Majithia on Thursday claimed that Punjab Chief Minister Bhagwant Mann was in the third or fourth stage of liver cirrhosis after he was admitted to a private hospital in Mohali.
Nandish Shah of HDFC Securities suggests ‘Bull Spread’ strategy on Nifty (27-09-2024)
Short term trend of the Nifty remains bullish as it is placed above its 5, 11 and 20 day EMA.
Advait Infratech: A detailed analysis (27-09-2024)
Thanks for sharing, but I fail to understand how is this profitable?
Net cost is 25k. So how is this profitable? You have considered profit of just 50$ /mw.
Nifty Pharma presents sell-on-rise opportunity; your trading strategy here (27-09-2024)
The Nifty Pharma Index remains range-bound, trading between 23,450 and 22,925. A close above or below these levels would act as a directional trigger, leading to either a bullish or bearish breakout.
Hindustan Foods (27-09-2024)
Hindustan Foods shares up 2% on merger with promoter‐owned entity
52 week highs and all time highs strategy (27-09-2024)
MARUTI SUZUKI INDIA LTD is nearing its all-time high record.
Weekly
Daily
Disclaimer: No Positions, This is not a recommendation to buy or sell and shared purely for educational purpose.
Stock Alpha: ChatGPT for Equity Research (27-09-2024)
Hi Sandeep- thanks for checking out Stock Alpha. While Screener is great at giving you structured tables of data & brief summaries of transcripts, our users still spent hours & weeks reading long annual reports, earnings calls & investor decks
A lot of company context & operational information, along with strategy details are captured in these documents which Screener fails to deliver
Using Stock Alpha- you have an Assistant available with you 24 x 7 that has context on hundreds of companies & their stock filings & can answer questions related to help you make better informed investment decisions
Would love your feedback 
Neuland Laboratories Limited – Transformation towards niche APIs? (27-09-2024)
KUDOS TO NEULAND LABS AND BMS